Adalta Share Price and Company Fundamentals



Price
$0.085
Change
-0.004 (-4.494%)
52 week
0.08 - 0.265

Last traded: Today at 4:11 AM

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to discover i-bodies that bind to granzyme B; and Carina Biotech Pty Ltd. to develop CAR-T cell products against various solid tumor antigens. AdAlta Limited was incorporated in 2006 and is based in Bundoora, Australia.

Key Metrics

PE ratio

-

PB ratio

3.34

Dividend yield

Beta

1.04

Market cap

$21.33M

Enterprise value

$17.23M

Company profile

Primary activitiesDrug discovery and development
Industry / SectorBiotechnology / Healthcare
Websitehttp://www.adalta.com.au
Mailing address2 Park Drive Unit 15 Bundoora VIC 3083 Australia
Phone / Fax61 3 9479 5159 / 61 2 8583 3040
Share registryAUTOMIC REGISTRY SERVICES

Dividends

Adalta does not pay dividends.

Company Executives

As of Oct 2021, following are the company executives and directors listed on Adalta.

NameTitleAgeTotal Pay
Dr. Timothy Charles Oldham B.Sc., BSc(Hons), L.L.B., LLB(Hons), Ph.D.CEO, MD & Director351.44k
Dr. Dallas HartmanChief Operating Officer
Prof. Michael Foley Ph.D.Chief Scientific Advisor & Chief Scientific Officer
Mr. Cameron Jones C.A.Company Sec.

Profitability and management effectiveness

Profit margin

-141.26%

Operating margin

-135.99%

Return on assets

-42.45%

Return on equity

-111.58%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Adalta is 21.33M and its enterprise value is 17.23M. The enterprise value to revenue ratio of 1AD is 20.31.

The 1AD's stocks Beta value is 1.04 making it 4% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Adalta (1AD)

Adalta (ASX:1AD) Frequently Asked Questions

1. What is Adalta's Stock Symbol?

Adalta trades on ASX under the ticker symbol "1AD".

2. What is Adalta's stock price today?

One share of 1AD stock can currently be purchased for approximately $0.085.

3. How can I contact Adalta?

Adalta's mailing address is 2 Park Drive Unit 15 Bundoora VIC 3083 Australia. The company can be reached via phone at 61 3 9479 5159.

4. What is Adalta's official website?

The official website of Adalta is http://www.adalta.com.au.

5. Which share registry manages Adalta's stock?

Adalta's stock is managed by AUTOMIC REGISTRY SERVICES.